Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Helium-3 MRI for Lung Deformation Assessment
NCT02995590Phase 1Unknown
- Sponsor
- University of Virginia
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of hyperpolarized helium-3, sponsored by University of Virginia. Primary endpoint: Development and optimization of methodology for measuring lung deformation. Status: unknown.
02
Drugs
hyperpolarized helium-3
Beyond the preview
Go deeper on NCT02995590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02995590.